Apyx Medical (APYX) Current Assets (2010 - 2026)

Apyx Medical (APYX) has reported Current Assets for 17 consecutive years, with $53.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 6.49% year-over-year to $53.2 million; the trailing twelve-month figure through Jun 2026 stood at $53.2 million (up 6.49% YoY), and the FY2025 full-year result was $58.5 million, up 3.6% from the prior year.
• Current Assets slipped to $53.2 million in Q2 2026 per APYX's latest filing, from $54.8 million in the prior quarter.
• Across five years, Current Assets topped out at $70.4 million in Q4 2023 and bottomed at $43.0 million in Q4 2022.
• Historically, Current Assets has averaged $53.6 million across 5 years, with a median of $52.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Current Assets fell 29.25% in 2022, then soared 63.74% in 2023.
• Over 5 years, Current Assets stood at $43.0 million in 2022, then jumped by 63.74% to $70.4 million in 2023, then retreated by 19.79% to $56.4 million in 2024, then gained by 3.6% to $58.5 million in 2025, then fell by 9.09% to $53.2 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $53.2 million, $54.8 million, and $58.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.